David Mountcastle sold $327k of PRVA
EVP & Chief Financial Officer at Privia Health Group, Inc.. 13,058 shares at an average of $25.03, traded Feb 26, 2026, filed Mar 2, 2026.
Score components
- +22RoleCFO
- +15Trade size$327k at market
- 0Share of holdings soldSold 7.3% of holdings
- +15Cluster4 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -12.4%, 3m -11.4%, 6m -14.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001759655-26-000013, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 26, 2026 | MOption exercise Common Stock, par value $0.01 per share10b5-1 | +5,361 | $2.00 | $11k | 178,270 | Mar 2, 2026 |
| Feb 26, 2026 | SOpen-market sale Common Stock, par value $0.01 per share10b5-1 | -5,361 | $25.00 | $134k | 172,909 | Mar 2, 2026 |
| Feb 27, 2026 | MOption exercise Common Stock, par value $0.01 per share10b5-1 | +7,697 | $2.00 | $15k | 180,606 | Mar 2, 2026 |
| Feb 27, 2026 | SOpen-market sale Common Stock, par value $0.01 per share10b5-1 | -7,697 | $25.05 | $193k | 172,909 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -1,668 | $0.00 | $0 | 3,833 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -1,100 | $0.00 | $0 | 11,352 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -1,893 | $0.00 | $0 | 15,927 | Mar 2, 2026 |
| Feb 26, 2026 | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -700 | $0.00 | $0 | 2,166 | Mar 2, 2026 |
| Feb 27, 2026 | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -998 | $0.00 | $0 | 2,835 | Mar 2, 2026 |
| Feb 27, 2026 | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -2,699 | $0.00 | $0 | 8,653 | Mar 2, 2026 |
| Feb 27, 2026 | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -3,428 | $0.00 | $0 | 12,499 | Mar 2, 2026 |
| Feb 27, 2026 | MOption exercise Stock Option (Right to Purchase)derivative10b5-1 | -572 | $0.00 | $0 | 1,594 | Mar 2, 2026 |
Related signals
Other insiders at Privia Health Group, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 59Moderate | Privia Health Group, Inc. | Parth Mehrotra Chief Executive Officer | $586k 26,509 shares | -5% | |
| 48Moderate | Privia Health Group, Inc. | David Mountcastle EVP & Chief Financial Officer | $141k 6,391 shares | -3% | |
| 65Notable | Privia Health Group, Inc. | Parth Mehrotra Chief Executive Officer | $1.2M 53,992 shares | -8% | |
| 51Moderate | Privia Health Group, Inc. | David Mountcastle EVP & Chief Financial Officer | $283k 13,018 shares | -5% | |
| 38Weak | Privia Health Group, Inc. | Parth Mehrotra Chief Executive Officer | $479k 21,097 shares | -6% | |
| 47Moderate | Privia Health Group, Inc. | Edward C Fargis EVP & General Counsel | $215k 9,343 shares | -10% | |
| 50Moderate | Privia Health Group, Inc. | Parth Mehrotra Chief Executive Officer | $1.5M 63,439 shares | -16% | |
| 50Moderate | Privia Health Group, Inc. | David Mountcastle EVP & Chief Financial Officer | $253k 11,006 shares | -6% | |
| 25Weak | Privia Health Group, Inc. | Matthew Shawn Morris director | $608k 24,338 shares | -32% | |
| 8Weak | Privia Health Group, Inc. | Matthew Shawn Morris director | $341k 13,647 shares | -17% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.